Prevention of Angiotensin II-Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2

被引:182
作者
Zhong, JiuChang
Guo, Danny
Chen, Christopher B.
Wang, Wang [5 ]
Schuster, Manfred [2 ]
Loibner, Hans [2 ]
Penninger, Josef M. [3 ]
Scholey, James W. [4 ]
Kassiri, Zamaneh [5 ]
Oudit, Gavin Y. [1 ,5 ]
机构
[1] Univ Alberta, Mazankowski Alberta Heart Inst, Dept Med, Div Cardiol, Edmonton, AB T6G 2S2, Canada
[2] Apeiron Biol, Vienna, Austria
[3] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria
[4] Univ Toronto, Dept Med, Div Nephrol, Toronto, ON, Canada
[5] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2S2, Canada
基金
中国国家自然科学基金;
关键词
angiotensin I; hypertension I; renal fibrosis; signal transduction; CHRONIC KIDNEY-DISEASE; PROXIMAL TUBULAR CELLS; INDUCED HYPERTENSION; PATHOLOGICAL HYPERTROPHY; ACE2; INJURY; EXPRESSION; MICE; DYSFUNCTION; INHIBITION;
D O I
10.1161/HYPERTENSIONAHA.110.164244
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angiotensin-converting enzyme 2 (ACE2) is a monocarboxypeptidase capable of metabolizing angiotensin (Ang) II into Ang 1 to 7. We hypothesized that ACE2 is a negative regulator of Ang II signaling and its adverse effects on the kidneys. Ang II infusion (1.5 mg/kg(-1)/d(-1)) for 4 days resulted in higher renal Ang II levels and increased nicotinamide adenine dinucleotide phosphate oxidase activity in ACE2 knockout (Ace2(-/y)) mice compared to wild-type mice. Expression of proinflammatory cytokines, interleukin-1 beta and chemokine (C-C motif) ligand 5, were increased in association with greater activation of extracellular-regulated kinase 1/2 and increase of protein kinase C-alpha levels. These changes were associated with increased expression of fibrosis-associated genes (alpha-smooth muscle actin, transforming growth factor-beta, procollagen type I alpha 1) and increased protein levels of collagen I with histological evidence of increased tubulointerstitial fibrosis. Ang II-infused wild-type mice were then treated with recombinant human ACE2 (2 mg/kg(-1)/d(-1), intraperitoneal). Daily treatment with recombinant human ACE2 reduced Ang II-induced pressor response and normalized renal Ang II levels and oxidative stress. These changes were associated with a suppression of Ang II-mediated activation of extracellular-regulated kinase 1/2 and protein kinase C pathway and Ang II-mediated renal fibrosis and T-lymphocyte-mediated inflammation. We conclude that loss of ACE2 enhances renal Ang II levels and Ang II-induced renal oxidative stress, resulting in greater renal injury, whereas recombinant human ACE2 prevents Ang II-induced hypertension, renal oxidative stress, and tubulointerstitial fibrosis. ACE2 is an important negative regulator of Ang II-induced renal disease and enhancing ACE2 action may have therapeutic potential for patients with kidney disease. (Hypertension. 2011;57:314-322.). Online Data Supplement
引用
收藏
页码:314 / U338
页数:18
相关论文
共 50 条
[41]   Angiotensin-Converting Enzyme Inhibitor Does Not Suppress Renal Angiotensin II Levels in Angiotensin I-Infused Rats [J].
Ohnishi, Keisuke ;
Murase, Miki ;
Nakano, Daisuke ;
Pelisch, Nicolas ;
Hitomi, Hirofumi ;
Kobori, Hiroyuki ;
Morimoto, Satoshi ;
Mori, Hirohito ;
Masaki, Tsutomu ;
Ohmori, Koji ;
Kohno, Masakazu ;
Ichihara, Atsuhiro ;
Nishiyama, Akira .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 122 (02) :103-108
[42]   Angiotensin-converting enzyme 2: a key enzyme in key organs [J].
Pagliaro, Pasquale ;
Thairi, Cecilia ;
Alloatti, Giuseppe ;
Penna, Claudia .
JOURNAL OF CARDIOVASCULAR MEDICINE, 2022, 23 (01) :1-11
[43]   RENAL TISSUE ANGIOTENSIN-II - RESPONSE TO INFUSIONS OF ANGIOTENSIN-I AND AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR [J].
REAMS, G ;
VILLARREAL, D ;
WU, Z ;
BAUER, JH .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (06) :851-857
[44]   Increased Urinary Angiotensin-Converting Enzyme 2 in Renal Transplant Patients with Diabetes [J].
Xiao, Fengxia ;
Hiremath, Swapnil ;
Knoll, Greg ;
Zimpelmann, Joseph ;
Srivaratharajah, Kajenny ;
Jadhav, Deepak ;
Fergusson, Dean ;
Kennedy, Chris R. J. ;
Burns, Kevin D. .
PLOS ONE, 2012, 7 (05)
[45]   Angiotensin II type 2 receptor and angiotensin-converting enzyme 2 mediate ischemic renal injury in diabetic and non-diabetic rats [J].
Sharma, Nisha ;
Malek, Vajir ;
Mulay, Shrikant R. ;
Gaikwad, Anil Bhanudas .
LIFE SCIENCES, 2019, 235
[46]   Urinary angiotensin-converting enzyme 2 and metabolomics in COVID-19-mediated kidney injury [J].
Vergara, Ander ;
Wang, Kaiming ;
Colombo, Daniele ;
Gheblawi, Mahmoud ;
Rasmuson, Jaslyn ;
Mandal, Rupasri ;
Del Nonno, Franca ;
Chiu, Brian ;
Scholey, James W. ;
Jose Soler, Maria ;
Wishart, David S. ;
Oudit, Gavin Y. .
CLINICAL KIDNEY JOURNAL, 2023, 16 (02) :272-284
[47]   Angiotensin-Converting Enzyme 2 Attenuates Bleomycin-Induced Lung Fibrosis in Mice [J].
Wang, Lifang ;
Wang, Yuxiang ;
Yang, Tuo ;
Guo, Yanfei ;
Sun, Tieying .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 36 (02) :697-711
[48]   Prevention of systemic inflammation and neuroprotective effects of Qingda granules against angiotensin II-mediated hypertension [J].
Zhang, Ling ;
Cai, Qiao-yan ;
Lin, Shan ;
Jia, Bei-bei ;
Ye, Ren-zhi ;
Wang, Huai ;
Bao, Li-ya ;
Chen, You-qin ;
Chu, Jian-feng ;
Peng, Jun .
PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 33 (01) :469-479
[49]   Angiotensin-Converting Enzyme 2-Independent Action of Presumed Angiotensin-Converting Enzyme 2 Activators Studies In Vivo, Ex Vivo, and In Vitro [J].
Haber, Philipp K. ;
Ye, Minghao ;
Wysocki, Jan ;
Maier, Christoph ;
Haque, Syed K. ;
Batlle, Daniel .
HYPERTENSION, 2014, 63 (04) :774-782
[50]   N-acetylcysteine alleviates angiotensin II-mediated renal fibrosis in mouse obstructed kidneys [J].
Shen, Yang ;
Miao, Nai-jun ;
Xu, Jin-lan ;
Gan, Xin-xin ;
Xu, Dan ;
Zhou, Li ;
Xue, Hong ;
Zhang, Wei ;
Lu, Li-min .
ACTA PHARMACOLOGICA SINICA, 2016, 37 (05) :637-644